IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 79 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $0 | -100.0% | 67 | -99.5% | 0.00% | -100.0% |
Q1 2018 | $25,000 | +2400.0% | 13,362 | +2950.7% | 0.00% | – |
Q4 2017 | $1,000 | -96.3% | 438 | -96.4% | 0.00% | -100.0% |
Q3 2017 | $27,000 | +200.0% | 12,203 | +115.0% | 0.00% | +100.0% |
Q2 2016 | $9,000 | +800.0% | 5,677 | +2143.9% | 0.00% | – |
Q1 2016 | $1,000 | -83.3% | 253 | -87.8% | 0.00% | -100.0% |
Q4 2015 | $6,000 | -87.5% | 2,074 | -85.5% | 0.00% | -80.0% |
Q3 2015 | $48,000 | +118.2% | 14,308 | +137.0% | 0.01% | +150.0% |
Q2 2015 | $22,000 | -83.8% | 6,038 | -83.5% | 0.00% | -88.2% |
Q1 2015 | $136,000 | +1033.3% | 36,590 | +1285.5% | 0.02% | +1600.0% |
Q4 2014 | $12,000 | -61.3% | 2,641 | -80.8% | 0.00% | -66.7% |
Q3 2014 | $31,000 | -70.2% | 13,733 | -61.7% | 0.00% | -76.9% |
Q2 2014 | $104,000 | +28.4% | 35,823 | +81.4% | 0.01% | +30.0% |
Q1 2014 | $81,000 | +8000.0% | 19,753 | +2628.3% | 0.01% | – |
Q3 2013 | $1,000 | – | 724 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |